实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
3期
342-345
,共4页
陈建平%张春江%赵丹%马莉%尹璇%杨晓萍
陳建平%張春江%趙丹%馬莉%尹璇%楊曉萍
진건평%장춘강%조단%마리%윤선%양효평
肾小球系膜细胞%1,25(OH)2D3%表皮生长因子%增殖%凋亡
腎小毬繫膜細胞%1,25(OH)2D3%錶皮生長因子%增殖%凋亡
신소구계막세포%1,25(OH)2D3%표피생장인자%증식%조망
Glomerular mesangial cells%1,25-dihydroxyvitamin D3%EGF%Pproliferation%Apoptosis
目的:探讨1,25-二羟维生素D3[1,25(OH)2D3]对人系膜细胞增殖与凋亡的影响。方法:体外培养人系膜细胞,随机分为4组:正常对照组、表皮生长因子(EGF)(10 ng/mL)组、1,25(OH)2D3(10-8 mol/L)组、EGF 联合1,25(OH)2D3干预组,采用CCK-8法检测各组干预48 h 后系膜细胞的增殖情况,流式细胞术检测各组干预48 h 后系膜细胞周期分布情况, TUNEL 法检测各组干预48 h 后系膜细胞凋亡情况。结果:与正常对照组相比,EGF组能显著促进系膜细胞增殖,G1期细胞显著减少,S期细胞显著增加,且凋亡指数显著降低(P<0.01),1,25(OH)2D3组系膜细胞增殖显著受抑制,G1期细胞增加,S期细胞减少,且凋亡指数增高(P<0.01);与EGF组比较,EGF联合1,25(OH)2D3干预组系膜细胞增殖显著受抑制,G1期细胞显著增多, S期细胞显著减少,且凋亡指数显著增高(P<0.01或P<0.05)。结论:1,25(OH)2D3可显著抑制人系膜细胞的增殖,促进其凋亡,且1,25(OH)2D3可抑制EGF对系膜细胞的促增殖作用及抑制凋亡的作用。
目的:探討1,25-二羥維生素D3[1,25(OH)2D3]對人繫膜細胞增殖與凋亡的影響。方法:體外培養人繫膜細胞,隨機分為4組:正常對照組、錶皮生長因子(EGF)(10 ng/mL)組、1,25(OH)2D3(10-8 mol/L)組、EGF 聯閤1,25(OH)2D3榦預組,採用CCK-8法檢測各組榦預48 h 後繫膜細胞的增殖情況,流式細胞術檢測各組榦預48 h 後繫膜細胞週期分佈情況, TUNEL 法檢測各組榦預48 h 後繫膜細胞凋亡情況。結果:與正常對照組相比,EGF組能顯著促進繫膜細胞增殖,G1期細胞顯著減少,S期細胞顯著增加,且凋亡指數顯著降低(P<0.01),1,25(OH)2D3組繫膜細胞增殖顯著受抑製,G1期細胞增加,S期細胞減少,且凋亡指數增高(P<0.01);與EGF組比較,EGF聯閤1,25(OH)2D3榦預組繫膜細胞增殖顯著受抑製,G1期細胞顯著增多, S期細胞顯著減少,且凋亡指數顯著增高(P<0.01或P<0.05)。結論:1,25(OH)2D3可顯著抑製人繫膜細胞的增殖,促進其凋亡,且1,25(OH)2D3可抑製EGF對繫膜細胞的促增殖作用及抑製凋亡的作用。
목적:탐토1,25-이간유생소D3[1,25(OH)2D3]대인계막세포증식여조망적영향。방법:체외배양인계막세포,수궤분위4조:정상대조조、표피생장인자(EGF)(10 ng/mL)조、1,25(OH)2D3(10-8 mol/L)조、EGF 연합1,25(OH)2D3간예조,채용CCK-8법검측각조간예48 h 후계막세포적증식정황,류식세포술검측각조간예48 h 후계막세포주기분포정황, TUNEL 법검측각조간예48 h 후계막세포조망정황。결과:여정상대조조상비,EGF조능현저촉진계막세포증식,G1기세포현저감소,S기세포현저증가,차조망지수현저강저(P<0.01),1,25(OH)2D3조계막세포증식현저수억제,G1기세포증가,S기세포감소,차조망지수증고(P<0.01);여EGF조비교,EGF연합1,25(OH)2D3간예조계막세포증식현저수억제,G1기세포현저증다, S기세포현저감소,차조망지수현저증고(P<0.01혹P<0.05)。결론:1,25(OH)2D3가현저억제인계막세포적증식,촉진기조망,차1,25(OH)2D3가억제EGF대계막세포적촉증식작용급억제조망적작용。
Objective To investigate the effects of 1,25-dihydroxyvitamin D3 on the proliferation and apoptosis of cultured human glomerular mesangial cells. Methods The cultured human glomerular mesangial cells were divided into four groups: the normal control group, the EGF (10 ng/mL) group, the 1,25-dihydroxyvitamin D3 (10-8 mol/L) group and the EGF in combination with 1,25-dihydroxyvitamin D3 group. Afterr 48-hours treatment, cell proliferation was measured by cell counting kit-8 (cck-8) assay, cell cycle was measured by flow cytometry, and cell apoptosis was measured by the TdT-mediated dUTP nick-end labeling (TUNEL) assay. Results Compared with the normal control, EGF could significantly promote the proliferation of human glomerular mesangial cells (P<0.01). The percentage of cells with G1 phase significantly decreased and the percentage of cells with S phase significantly increased (P < 0.01). The apoptosis index of the human glomerular mesangial cells significantly decreased in the EGF group (P < 0.01). 1,25-dihydroxyvitamin D3 could significantly inhibit the proliferation of human glomerular mesangial cells (P<0.01). 1,25-dihydroxyvitamin D3 could significantly increase the percentage of G1 phase cells and could decrease the percentage of S phase cells (P<0.01), and could significantly increase the apoptosis index of human glomerular mesangial cells (P<0.01). Compared with EGF, EGF in combination with 1,25-dihydroxyvitamin D3 could significantly inhibit the proliferation of human glomerular mesangial cells (P <0.01). The percentage of G1 phase cells significantly increased and the percentage of S phase cellssignificantly decreased (P < 0.01), and the cell apoptosis index significantly increased in the EGF in combination with 1,25-dihydroxyvitamin D3 group (P < 0.05). Conclusions (1) 1,25-dihydroxyvitamin D3 could significantly inhibit the proliferation and promote the apoptosis of human glomerular mesangial cells. (2) 1,25-dihydroxyvitamin D3 could also inhibit the proliferation of EGF-induced human glomerular mesangial cells.